Company registration number 14700315 (England and Wales)
SLEEP BRANDS LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2024
Affinia
19th Floor
1 Westfield Avenue
London
E20 1HZ
SLEEP BRANDS LIMITED
COMPANY INFORMATION
Directors
Mr G A Fazio
Ms K Fazio
Company number
14700315
Registered office
376 London Road
High Wycombe
HP11 1LH
Auditor
Affinia (Stratford)
19th Floor
1 Westfield Avenue
London
E20 1HZ
Bankers
HSBC UK Bank Plc
130 New Street
West Midlands
Birmingham
England
B2 4JU
Revolut Ltd
7 Westferry Circus
Canary Wharf
London
E14 4HD
SLEEP BRANDS LIMITED
CONTENTS
Page
Strategic report
1 - 2
Directors' report
3
Directors' responsibilities statement
4
Independent auditor's report
5 - 8
Profit and loss account
9
Group statement of comprehensive income
10
Group balance sheet
11
Company balance sheet
12
Group statement of changes in equity
13
Company statement of changes in equity
14
Group statement of cash flows
15
Notes to the financial statements
16 - 36
SLEEP BRANDS LIMITED
STRATEGIC REPORT
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 1 -

The directors present the strategic report for the period ended 31 December 2024.

Principal activities

The principal activity of Sleep Brands Limited and subsidiaries in the period under review is the design and retail of contemporary furniture and homeware accessories under the ‘Swyft’ brand name through its own online website and retail partners.

Review of the business

The group has shown a strong performance despite the reduced levels of profitability being driven by macro-economic factors led by the cost of living crisis. The directors are pleased with the performance of the group and feel it is well placed for growth in the future as economic pressures soften.

The retail market for upholstered furniture in the UK is highly competitive. The group’s success is therefore dependent on its ability to compete effectively, particularly during peak trading periods. The group continues to make substantial investments in marketing to maintain its leading brand status. This year, the group has continued to expand our online reach, tapping into emerging markets and optimising our digital platforms.

Next year, we will focus on growing our presence in emerging markets, expanding our product range, and strengthening our partner relationships. Since the year-end we have already launched our new ranges of dining and living room furniture and look to offer more products within this range as well as further products for other rooms within the home. We will continue to design and innovate our existing products such as sofas and beds. Another key focus for the year ahead is the improvement of our gross profit margin through streamlining of our manufacturing process and shortening the time it takes for goods to be delivered from date of ordering.

"Our mission is to make stylish, sustainable furniture accessible to all, revolutionising the way people shop for their homes online."

Strengths: Strong online presence, established customer base, and competitive pricing.

Weaknesses: High customer acquisition costs, historic high fixed costs.

Opportunities: Diversifying our product range, improving gross margin and reducing fixed costs.

Threats: Rising shipping costs and increasing competition.

Key performance indicators

The group uses a number of financial measures to monitor progress against strategies and corporate objectives.

The below details the key financial measures that the directors assess, disregarding the mid year acquisition of Lombok Investments Limited and subsidiaries.

These are the non consolidated figures with, the December 2024 figures covering the 11 month period to this date, and the January 2024 the year to this date. The directors feel that these non consolidated figures represent the best way of reviewing the performance of the business, as opposed to using the numbers reported in these statutory financial statements.

 

 

Dec 2024

 

Jan 2024

 

 

£

 

£

 

 

 

 

 

Turnover

 

22,173,167

 

22,348,604

Gross Profit

 

9,953,749

 

8,361,543

Gross Profit %

 

44.89%

 

37.41%

EBITDA

(1,051,064)

(4,962,883)

SLEEP BRANDS LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 2 -

On behalf of the board

K Fazio
Director
28 November 2025
SLEEP BRANDS LIMITED
DIRECTORS' REPORT
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 3 -

The directors present their annual report and financial statements for the period ended 31 December 2024.

Results and dividends

The results for the period are set out on page 9.

No ordinary dividends were paid. The directors do not recommend payment of a further dividend.

Directors

The directors who held office during the period and up to the date of signature of the financial statements were as follows:

Mr G A Fazio
Ms K Fazio
Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the auditor of the company is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the auditor of the company is aware of that information.

Medium-sized companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the medium-sized companies regime.

On behalf of the board
K Fazio
Director
28 November 2025
SLEEP BRANDS LIMITED
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 4 -

The directors are responsible for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the group and company, and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

 

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the group’s and company’s transactions and disclose with reasonable accuracy at any time the financial position of the group and company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the group and company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

SLEEP BRANDS LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF SLEEP BRANDS LIMITED
- 5 -
Opinion

We have audited the financial statements of Sleep Brands Limited (the 'parent company') and its subsidiaries (the 'group') for the period ended 31 December 2024 which comprise the group profit and loss account, the group statement of comprehensive income, the group balance sheet, the company balance sheet, the group statement of changes in equity, the company statement of changes in equity, the group statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the group and parent company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

SLEEP BRANDS LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF SLEEP BRANDS LIMITED
- 6 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the group and the parent company and their environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.

 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the parent company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

SLEEP BRANDS LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF SLEEP BRANDS LIMITED
- 7 -

Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, incorporated the following:

 

 

We assessed the susceptibility of the company’s financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:

 

 

To address the risk of fraud through management bias and override of controls, our work included:

 

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:

 

 

There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any.

 

Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Other matters which we are required to address

The previous year's financial statements have not been audited and accordingly, we do not express an opinion on them.

SLEEP BRANDS LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF SLEEP BRANDS LIMITED
- 8 -

Use of our report

This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

Richard Lane (Senior Statutory Auditor)
For and on behalf of Affinia (Stratford), Statutory Auditor
Chartered Accountants
19th Floor
1 Westfield Avenue
London
E20 1HZ
28 November 2025
SLEEP BRANDS LIMITED
GROUP PROFIT AND LOSS ACCOUNT
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 9 -
Period
Year
ended
ended
31
31
December 2024
March 2024 (unaudited and company only)
as restated
Notes
£
£
Turnover
3
16,746,296
359,952
Cost of sales
(7,881,042)
-
0
Gross profit
8,865,254
359,952
Distribution costs
(5,355,909)
-
0
Administrative expenses
(5,451,047)
(74,657)
Other operating income
99,904
-
Exceptional item
4
(713,924)
-
0
Operating (loss)/profit
5
(2,555,722)
285,295
Interest payable and similar expenses
9
(268,382)
-
0
(Loss)/profit before taxation
(2,824,104)
285,295
Tax on (loss)/profit
10
7,917
(71,797)
(Loss)/profit for the financial period
22
(2,816,187)
213,498
(Loss)/profit for the financial period is all attributable to the owners of the parent company.
SLEEP BRANDS LIMITED
GROUP STATEMENT OF COMPREHENSIVE INCOME
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 10 -
Period
Year
ended
ended
31
31
December 2024
March 2024 (unaudited and company only)
as restated
£
£
(Loss)/profit for the period
(2,816,187)
213,498
Other comprehensive income
-
-
Cash flow hedges gain arising in the period
-
0
-
0
Total comprehensive income for the period
(2,816,187)
213,498
Total comprehensive income for the period is attributable to:
- Owners of the parent company
(2,575,546)
213,498
- Non-controlling interests
(240,641)
-
0
(2,816,187)
213,498
SLEEP BRANDS LIMITED
GROUP BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
- 11 -
December 2024
March 2024 (unaudited and company only)
as restated
Notes
£
£
£
£
Fixed assets
Goodwill
13
4,000,000
-
0
Other intangible assets
13
169,365
5,055
Total intangible assets
4,169,365
5,055
Tangible assets
14
233,257
235
4,402,622
5,290
Current assets
Stocks
17
550,100
-
Debtors
18
3,014,285
73,378
Cash at bank and in hand
531,089
96,629
4,095,474
170,007
Creditors: amounts falling due within one year
19
(11,290,180)
(71,797)
Net current (liabilities)/assets
(7,194,706)
98,210
Net (liabilities)/assets
(2,792,084)
103,500
Capital and reserves
Called up share capital
21
2
2
Other reserves
22
(79,397)
-
0
Profit and loss reserves
22
(2,472,048)
103,498
Equity attributable to owners of the parent company
(2,551,443)
103,500
Non-controlling interests
(240,641)
-
0
Total equity
(2,792,084)
103,500

These financial statements have been prepared in accordance with the provisions relating to medium-sized groups.

The financial statements were approved by the board of directors and authorised for issue on 28 November 2025 and are signed on its behalf by:
28 November 2025
K Fazio
Director
Company registration number 14700315 (England and Wales)
SLEEP BRANDS LIMITED
COMPANY BALANCE SHEET
AS AT 31 DECEMBER 2024
31 December 2024
- 12 -
December 2024
March 2024 (unaudited)
as restated
Notes
£
£
£
£
Fixed assets
Intangible assets
4,659
5,055
Tangible assets
14
37,341
235
Investments
15
723,000
-
0
765,000
5,290
Current assets
Debtors
18
3,645,306
73,378
Cash at bank and in hand
25,136
96,629
3,670,442
170,007
Creditors: amounts falling due within one year
19
(4,059,659)
(71,797)
Net current (liabilities)/assets
(389,217)
98,210
Net assets
375,783
103,500
Capital and reserves
Called up share capital
21
2
2
Profit and loss reserves
22
375,781
103,498
Total equity
375,783
103,500

As permitted by s408 Companies Act 2006, the company has not presented its own profit and loss account and related notes. The company’s profit for the year was £272,283 (March 2024 (unaudited) - £213,498 profit).

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 28 November 2025 and are signed on its behalf by:
28 November 2025
K Fazio
Director
Company registration number 14700315 (England and Wales)
SLEEP BRANDS LIMITED
GROUP STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 13 -
Share capital
Foreign translation reserve
Profit and loss reserves
Total controlling interest
Non-controlling interest
Total
Notes
£
£
£
£
£
£
As restated for the period ended 31 March 2024:
Balance at 1 April 2023
-
0
-
-
0
-
-
-
Year ended 31 March 2024:
Profit and total comprehensive income
-
-
213,498
213,498
-
213,498
Issue of share capital
21
2
-
-
2
-
2
Dividends
11
-
-
(110,000)
(110,000)
-
(110,000)
Balance at 31 March 2024
2
-
103,498
103,500
-
0
103,500
Period ended 31 December 2024:
Loss for the period
-
-
(2,816,187)
(2,816,187)
-
(2,816,187)
Other comprehensive income:
Amounts attributable to non-controlling interests
-
-
240,641
240,641
(240,641)
-
Total comprehensive income
-
-
(2,575,546)
(2,575,546)
(240,641)
(2,816,187)
Impact of translation of overseas subsidiaries
-
(79,397)
-
(79,397)
-
(79,397)
Balance at 31 December 2024
2
(79,397)
(2,472,048)
(2,551,443)
(240,641)
(2,792,084)
SLEEP BRANDS LIMITED
COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 14 -
Share capital
Foreign translation reserve
Profit and loss reserves
Total
Notes
£
£
£
£
As restated for the period ended 31 March 2024:
Balance at 1 April 2023
-
0
-
-
0
-
Year ended 31 March 2024:
Profit and total comprehensive income for the year
-
-
213,498
213,498
Issue of share capital
21
2
-
-
2
Dividends
11
-
-
(110,000)
(110,000)
Balance at 31 March 2024
2
-
103,498
103,500
Period ended 31 December 2024:
Profit and total comprehensive income
-
-
272,283
272,283
Balance at 31 December 2024
2
-
375,781
375,783
SLEEP BRANDS LIMITED
GROUP STATEMENT OF CASH FLOWS
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 15 -
December 2024
March 2024 (unaudited and company only)
as restated
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from operations
29
1,121,458
212,227
Interest paid
(268,382)
-
0
Net cash inflow from operating activities
853,076
212,227
Investing activities
Purchase of business, less cash acquired
(300,075)
-
Purchase of intangible assets
-
(5,275)
Purchase of tangible fixed assets
(39,144)
(325)
Net cash used in investing activities
(339,219)
(5,600)
Financing activities
Proceeds from issue of shares
-
2
Foreign translation reserve
(79,397)
-
Dividends paid to equity shareholders
-
0
(110,000)
Net cash used in financing activities
(79,397)
(109,998)
Net increase in cash and cash equivalents
434,460
96,629
Cash and cash equivalents at beginning of period
96,629
-
0
Cash and cash equivalents at end of period
531,089
96,629
SLEEP BRANDS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 16 -
1
Accounting policies
Company information

Sleep Brands Limited (“the company”) is a private limited company domiciled and incorporated in England and Wales. The registered office is 376 London Road, High Wycombe, HP11 1LH.

 

The group consists of Sleep Brands Limited and all of its subsidiaries.

1.1
Reporting period

These financial statements are prepared over the 9 month period to 31 December 2024. The previous period was covered the 13 month period to 31 March 2024. Hence, comparatives may not be entirely comparable.

 

Furthermore the comparative financial statements relate to the company only as the group came into being on 26 April 2024 following the acquisition of the entire share capital of Lombok Investments Ltd and its subsidiaries.

 

As the group only came into existence during the current year, all comparative information relates to the company only.

1.2
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.3
Business combinations

In the parent company financial statements, the cost of a business combination is the fair value at the acquisition date of the assets given, equity instruments issued and liabilities incurred or assumed, plus costs directly attributable to the business combination. The excess of the cost of a business combination over the fair value of the identifiable assets, liabilities and contingent liabilities acquired is recognised as goodwill. The cost of the combination includes the estimated amount of contingent consideration that is probable and can be measured reliably, and is adjusted for changes in contingent consideration after the acquisition date. Provisional fair values recognised for business combinations in previous periods are adjusted retrospectively for final fair values determined in the 12 months following the acquisition date. Investments in subsidiaries, joint ventures and associates are accounted for at cost less impairment.

 

Deferred tax is recognised on differences between the value of assets (other than goodwill) and liabilities recognised in a business combination accounted for using the purchase method and the amounts that can be deducted or assessed for tax, considering the manner in which the carrying amount of the asset or liability is expected to be recovered or settled. The deferred tax recognised is adjusted against goodwill or negative goodwill.

SLEEP BRANDS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 17 -
1.4
Basis of consolidation

The consolidated group financial statements consist of the financial statements of the parent company Sleep Brands Limited together with all entities controlled by the parent company (its subsidiaries) and the group’s share of its interests in joint ventures and associates.

 

All financial statements are made up to 31 December 2024. Where necessary, adjustments are made to the financial statements of subsidiaries to bring the accounting policies used into line with those used by other members of the group.

 

All intra-group transactions, balances and unrealised gains on transactions between group companies are eliminated on consolidation. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred.

Subsidiaries are consolidated in the group’s financial statements from the date that control commences until the date that control ceases.

Entities in which the group holds an interest and which are jointly controlled by the group and one or more other venturers under a contractual arrangement are treated as joint ventures. Entities other than subsidiary undertakings or joint ventures, in which the group has a participating interest and over whose operating and financial policies the group exercises a significant influence, are treated as associates.

Investments in joint ventures and associates are carried in the group balance sheet at cost plus post-acquisition changes in the group’s share of the net assets of the entity, less any impairment in value. The carrying values of investments in joint ventures and associates include acquired goodwill.

 

If the group’s share of losses in a joint venture or associate equals or exceeds its investment in the joint venture or associate, the group does not recognise further losses unless it has incurred obligations to do so or has made payments on behalf of the joint venture or associate.

 

Unrealised gains arising from transactions with joint ventures and associates are eliminated to the extent of the group’s interest in the entity.

1.5
Going concern

At the time of approving the financial statements, the directors have a reasonable expectation that the group has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

 

During the year the group made a loss of £2,816,187 (31 March 2024: profit of £213,498) and had net liabilities of £2,792,084 (31 March 2024: surplus of £103,500). During the period, the main trading subsidiary company underwent a change in ownership in Spring 2024, with new investors, being the parent company, committing substantial financial resources to fund operational restructuring. As at 31 December 2024 the Group owed its directors a total if £4,034,000 and the directors have expressed their intention to continue supporting the group. There is no fixed repayment date and these funds will no be repayable until the group is in a position to do so.

 

The management, supported by this new investment, anticipates this restructuring will significantly increase the profitability and improve cash flows for the company from Autumn/Winter 2025. Given these developments, management believes that the company’s financial stability is sufficiently assured to continue as a going concern.

 

SLEEP BRANDS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 18 -
1.6
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

 

When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.7
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

1.8
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of a business over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years.

 

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

1.9
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

 

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Patents & licences
10 year straight line
Development costs
10 year straight line
1.10
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

SLEEP BRANDS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 19 -

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
3-5 years straight line
Computers
2-10 years straight line
Motor vehicles
5 years straight line or 25% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the profit and loss account.

1.11
Fixed asset investments

Equity investments are measured at fair value through profit or loss, except for those equity investments that are not publicly traded and whose fair value cannot otherwise be measured reliably, which are recognised at cost less impairment until a reliable measure of fair value becomes available.

 

In the parent company financial statements, investments in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses.

A subsidiary is an entity controlled by the group. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The group considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

 

Investments in associates are initially recognised at the transaction price (including transaction costs) and are subsequently adjusted to reflect the group’s share of the profit or loss, other comprehensive income and equity of the associate using the equity method. Any difference between the cost of acquisition and the share of the fair value of the net identifiable assets of the associate on acquisition is recognised as goodwill. Any unamortised balance of goodwill is included in the carrying value of the investment in associates.

 

Losses in excess of the carrying amount of an investment in an associate are recorded as a provision only when the company has incurred legal or constructive obligations or has made payments on behalf of the associate.

 

In the parent company financial statements, investments in associates are accounted for at cost less impairment.

Entities in which the group has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.12
Impairment of fixed assets

At each reporting period end date, the group reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the group estimates the recoverable amount of the cash-generating unit to which the asset belongs.

 

The carrying amount of the investments accounted for using the equity method is tested for impairment as a single asset. Any goodwill included in the carrying amount of the investment is not tested separately for impairment.

SLEEP BRANDS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 20 -

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.13
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.14
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.15
Financial instruments

The group has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the group's balance sheet when the group becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

SLEEP BRANDS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 21 -
Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the group transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the group after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

SLEEP BRANDS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 22 -
Other financial liabilities

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.

 

Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

Derecognition of financial liabilities

Financial liabilities are derecognised when the group's contractual obligations expire or are discharged or cancelled.

1.16
Equity instruments

Equity instruments issued by the group are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the group.

1.17
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The group’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset if, and only if, there is a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

SLEEP BRANDS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 23 -
1.18
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the group is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.19
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.20
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leased asset are consumed.

2
Judgements and key sources of estimation uncertainty

In the application of the group’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

The following are considered to be the critical judgements of the Group.

Stock provisioning

Management estimates that a portion of stock at the year end will be sold at lower than cost with amount of £250,000 (31 January 2024: £200,000). This amount is made for impairment on the basis that any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss.

Bad debts provision

Provision for bad debt has is judged at 15% of closing debtor balance as at 31 December 2024. The key assumptions take account of the management's expectations for the period. These expectations consider the industry and the market conditions, the experience in working with customers and any other circumstances particular to the customers, warranty and returns.

SLEEP BRANDS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
2
Judgements and key sources of estimation uncertainty
(Continued)
- 24 -
Key sources of estimation uncertainty

The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows.

Depreciation and amortisation

The annual depreciation charge for the tangible assets is sensitive to changes in the estimated useful economic lives and residual value of the assets. The useful economic lives and residual value are re-assessed annually. They are amended when necessary to reflect current estimates, based on technological advancement, future investments, economic utilisation and the physical condition of assets.

Impairment of investments in subsidaries

The Group tests annually the carrying value of any investment in subsidiaries for impairment in accordance with the accounting policy stated. The recoverable amounts have been determined based on value-in-use calculations.

Impairment of goodwill

The Group tests annually whether goodwill and other intangibles have suffered any impairment in accordance with the accounting policy stated. The recoverable amounts have been determined based on value-in-use calculations.

3
Turnover
December 2024
March 2024 (unaudited)
£
£
Turnover analysed by class of business
Retail
14,373,406
-
Trade
2,115,509
-
Other
257,381
359,952
16,746,296
359,952
4
Exceptional item
December 2024
March 2024 (unaudited)
£
£
Expenditure
Restructure costs
713,924
713,924
-

During the year the group incurred costs of £713,924 relating to the restructure of an overseas operation.

SLEEP BRANDS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 25 -
5
Operating (loss)/profit
December 2024
March 2024 (unaudited)
£
£
Operating (loss)/profit for the period is stated after charging/(crediting):
Exchange gains
(6,185)
-
Research and development costs
52,443
-
Fees payable to the group's auditor for the audit of the group's financial statements
-
-
Depreciation of owned tangible fixed assets
58,798
90
Amortisation of intangible assets
449,731
220
Impairment of intangible assets
761,037
-
0
Operating lease charges
204,415
-
6
Auditor's remuneration
December 2024
March 2024 (unaudited)
Fees payable to the company's auditor and associates:
£
£
For audit services
Audit of the financial statements of the group and company
5,000
-
Audit of the financial statements of the company's subsidiaries
26,500
-
31,500
-
7
Employees

The average monthly number of persons (including directors) employed by the group and company during the period was:

Group
Company
December 2024
March 2024 (unaudited)
December 2024
March 2024 (unaudited)
Number
Number
Number
Number
63
2
2
2

Their aggregate remuneration comprised:

Group
Company
December 2024
March 2024 (unaudited)
December 2024
March 2024 (unaudited)
£
£
£
£
Wages and salaries
2,663,700
18,192
13,644
18,192
Social security costs
455,050
-
208
-
Pension costs
59,541
-
0
-
0
-
0
3,178,291
18,192
13,852
18,192
SLEEP BRANDS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 26 -
8
Directors' remuneration
December 2024
March 2024 (unaudited)
£
£
Remuneration for qualifying services
13,644
18,192
9
Interest payable and similar expenses
December 2024
March 2024 (unaudited)
£
£
Interest on financial liabilities measured at amortised cost:
Interest on bank overdrafts and loans
231,270
-
Interest on invoice finance arrangements
5,039
-
0
236,309
-
Other finance costs:
Finance costs for financial instruments measured at fair value through profit or loss
36,736
-
0
Other interest
(4,663)
-
Total finance costs
268,382
-
0
10
Taxation
December 2024
March 2024 (unaudited)
£
£
Current tax
UK corporation tax on profits for the current period
(7,917)
71,797

The actual (credit)/charge for the period can be reconciled to the expected (credit)/charge for the period based on the profit or loss and the standard rate of tax as follows:

December 2024
March 2024 (unaudited)
£
£
(Loss)/profit before taxation
(2,824,104)
285,295
Expected tax (credit)/charge based on the standard rate of corporation tax in the UK of 25.00% (March 2024 (unaudited): 25.00%)
(706,026)
71,324
Tax effect of expenses that are not deductible in determining taxable profit
190,868
78
Unutilised tax losses carried forward
507,241
-
0
Permanent capital allowances in excess of depreciation
-
0
(81)
Other permanent differences
-
0
476
Taxation (credit)/charge
(7,917)
71,797
SLEEP BRANDS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 27 -
11
Dividends
December 2024
March 2024 (unaudited)
Recognised as distributions to equity holders:
£
£
Final paid
-
110,000
12
Impairments

Impairment tests have been carried out where appropriate and the following impairment losses have been recognised in profit or loss:

December 2024
March 2024 (unaudited)
Notes
£
£
In respect of:
Goodwill
13
761,037
-
Recognised in:
Administrative expenses
761,037
-

The impairment losses in respect of financial assets are recognised in other gains and losses in the profit and loss account.

13
Intangible fixed assets
Group
Goodwill
Patents & licences
Development costs
Total
£
£
£
£
Cost
At 1 April 2024
-
0
5,275
-
0
5,275
Additions - on acqusition
5,101,111
-
0
-
0
5,101,111
Additions - business combinations
-
0
74,729
199,238
273,967
At 31 December 2024
5,101,111
80,004
199,238
5,380,353
Amortisation and impairment
At 1 April 2024
-
0
220
-
0
220
Amortisation charged for the period
340,074
8,224
101,433
449,731
Impairment losses
761,037
-
0
-
0
761,037
At 31 December 2024
1,101,111
8,444
101,433
1,210,988
Carrying amount
At 31 December 2024
4,000,000
71,560
97,805
4,169,365
At 31 March 2024
-
0
5,055
-
0
5,055
SLEEP BRANDS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
13
Intangible fixed assets
(Continued)
- 28 -
Company
Patents & licences
£
Cost
At 1 April 2024 and 31 December 2024
5,275
Amortisation and impairment
At 1 April 2024
220
Amortisation charged for the period
396
At 31 December 2024
616
Carrying amount
At 31 December 2024
4,659
At 31 March 2024
5,055

 

14
Tangible fixed assets
Group
Plant and equipment
Computers
Motor vehicles
Total
£
£
£
£
Cost
At 1 April 2024
-
0
325
-
0
325
Additions - separately acquired
-
0
-
0
39,144
39,144
Additions - business combinations
235,822
12,886
3,968
252,676
At 31 December 2024
235,822
13,211
43,112
292,145
Depreciation and impairment
At 1 April 2024
-
0
90
-
0
90
Depreciation charged in the period
52,832
3,291
2,675
58,798
At 31 December 2024
52,832
3,381
2,675
58,888
Carrying amount
At 31 December 2024
182,990
9,830
40,437
233,257
At 31 March 2024
-
0
235
-
0
235
SLEEP BRANDS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
14
Tangible fixed assets
(Continued)
- 29 -
Company
Computers
Motor vehicles
Total
£
£
£
Cost
At 1 April 2024
325
-
0
325
Additions
-
0
39,144
39,144
At 31 December 2024
325
39,144
39,469
Depreciation and impairment
At 1 April 2024
90
-
0
90
Depreciation charged in the period
81
1,957
2,038
At 31 December 2024
171
1,957
2,128
Carrying amount
At 31 December 2024
154
37,187
37,341
At 31 March 2024
235
-
0
235
15
Fixed asset investments
Group
Company
December 2024
March 2024 (unaudited)
December 2024
March 2024 (unaudited)
Notes
£
£
£
£
Investments in subsidiaries
16
-
0
-
0
723,000
-
0
Movements in fixed asset investments
Company
Shares in subsidiaries
£
Cost or valuation
At 1 April 2024
-
Additions
723,000
At 31 December 2024
723,000
Carrying amount
At 31 December 2024
723,000
At 31 March 2024
-
16
Subsidiaries

Details of the company's subsidiaries at 31 December 2024 are as follows:

SLEEP BRANDS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
16
Subsidiaries
(Continued)
- 30 -
Name of undertaking
Registered office
Class of
% Held
shares held
Direct
Indirect
Lombok Investments Limited
376 London Road, High Wycombe, HP11 1LH
Ordinary and preference shares
90.00
-
Swyft Home Limited
376 London Road, High Wycombe, HP11 1LH
Ordinary shares
0
90.00
Swyft Home Europe, Unipessoal, LDA
Rua de Sá nº741 4475-161 Maia, Portugal
Ordinary shares
0
90.00

On 26 April 2024, the company purchased 90% of share capital of Lombok Investments. Lombok Investments owns 100% of the share capital of Swyft Home Limited and Swyft Home Europe.

 

During the year, a subsidiary, Lombok Retail Limited, was placed into liquidation.

17
Stocks
Group
Company
December 2024
March 2024 (unaudited)
December 2024
March 2024 (unaudited)
£
£
£
£
Finished goods and goods for resale
550,100
-
0
-
0
-
0
18
Debtors
Group
Company
December 2024
March 2024 (unaudited)
December 2024 (restated)
March 2024 (unaudited)
Amounts falling due within one year:
£
£
£
£
Trade debtors
1,342,393
-
0
-
0
-
0
Amounts owed by group undertakings
-
-
3,260,361
-
Other debtors
1,268,397
1,378
312,945
1,378
Prepayments and accrued income
386,697
72,000
72,000
72,000
2,997,487
73,378
3,645,306
73,378
Amounts falling due after more than one year:
Other debtors
16,798
-
0
-
0
-
0
Total debtors
3,014,285
73,378
3,645,306
73,378
SLEEP BRANDS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 31 -
19
Creditors: amounts falling due within one year
Group
Company
December 2024
March 2024 (unaudited)
December 2024
March 2024 (unaudited)
£
£
£
£
Payments received on account
810,206
-
0
-
0
-
0
Trade creditors
3,640,972
-
0
-
0
-
0
Corporation tax payable
28,587
71,797
25,659
71,797
Other taxation and social security
2,179,658
-
-
-
Other creditors
4,146,334
-
0
4,034,000
-
0
Accruals and deferred income
484,423
-
0
-
0
-
0
11,290,180
71,797
4,059,659
71,797
20
Retirement benefit schemes
December 2024
March 2024 (unaudited)
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
59,541
-

A defined contribution pension scheme is operated for all qualifying employees. The assets of the scheme are held separately from those of the group in an independently administered fund.

21
Share capital
Group and company
December 2024
March 2024 (unaudited)
December 2024
March 2024 (unaudited)
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary Shares of £1 each
2
2
2
2
22
Reserves
Foreign translation reserve

Foreign translation reserves relate to the translation of the results of subsidiaries with a functional currency different to that of the group.

SLEEP BRANDS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 32 -
23
Acquisition of a business

On 26 April 2025 the group acquired 90% percent of the issued capital of Lombok Investements Ltd and its wholly owned subsidiaries.

Book Value
Adjustments
Fair Value
Net assets acquired
£
£
£
Intangible assets
255,316
-
255,316
Property, plant and equipment
110,685
-
110,685
Inventories
950,987
-
950,987
Trade and other receivables
2,732,763
-
2,732,763
Cash and cash equivalents
422,924
-
422,924
Trade and other payables
(8,850,786)
-
(8,850,786)
Total identifiable net assets
(4,378,111)
-
(4,378,111)
Goodwill
5,101,111
Total consideration
723,000
The consideration was satisfied by:
£
Cash
723,000
Contribution by the acquired business for the reporting period included in the group statement of comprehensive income since acquisition:
£
Turnover
16,530,295
Loss after tax
(1,794,626)
24
Operating lease commitments
Lessee

At the reporting end date the group had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

Group
Company
December 2024
March 2024 (unaudited)
December 2024
March 2024 (unaudited)
£
£
£
£
Within one year
258,876
-
-
-
Between two and five years
258,882
-
-
-
517,758
-
-
-
SLEEP BRANDS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 33 -
25
Security

Charges in the year

 

Industrial Lending 1 Sa created a charge on 28 March 2023 on all property or undertaking of the Swyft Home Limited, a subsidiary of the company.

This charge was satisfied on 8 May 2024.

White Oak No.6 Limited created a charge on 26 June 2023, against Swyft Home Limited, a subsidiary of the company. The relevant obligor, with full title guarantee in accordance with the law of property (miscellaneous provisions) act 1994 charges in favour of white oak as continuing security for the payment and discharge of the secured obligations: 4.1.2: by way of fixed charge, any real property now or at any time after the date of this deed belonging to any obligor (other than property charged under clause 4.1.1) 4.1.7 by way of fixed charge, all present and future intellectual property rights owned by it; real property (a) as defined in the finance agreement and any freehold, leasehold or other immovable property (including the property specified in part 1 of schedule 2 (if any)); and (b) any buildings, erections, fixtures or fittings from time to time situated on or forming part of such property (including any trade fixtures and fittings); and (c) all related rights. The charge also contains a floating charge which covers all the property or undertaking of the company.

This charge was satisfied on 21 May 2024.

 

26
Events after the reporting date

Subsequent to the year end, a subsidiary of the group secured £1,500,000, an interest-bearing loan from from a related party at an average rate of 6.6%. The loan is repayable by 31 December 2025.

27
Related party transactions

At the balance sheet date, the group owed the directors £4,034,000. These amounts are interest free and included within creditors due within one year.

 

The directors of Sleep Brands Limited and Swyft Home Europe are considered to be the key management personnel of the group. They were remunerated £132,444 for the 11 month period to December 2024.

28
Ultimate controlling party

By virtue of owning the entire share capital of the company, the directors are considered to be the ultimate controlling party.

SLEEP BRANDS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 34 -
29
Cash generated from group operations
December 2024
March 2024 (unaudited)
£
£
(Loss)/profit after taxation
(2,816,187)
213,498
Adjustments for:
Taxation (credited)/charged
(7,917)
71,797
Finance costs
268,382
-
0
Amortisation and impairment of intangible assets
1,210,768
220
Depreciation and impairment of tangible fixed assets
58,798
90
Movements in working capital:
Decrease in stocks
400,887
-
Increase in debtors
(208,144)
(73,378)
Increase in creditors
2,214,871
-
Cash generated from operations
1,121,458
212,227
30
Analysis of changes in net funds - group
1 April 2024
Cash flows
31 December 2024
£
£
£
Cash at bank and in hand
96,629
434,460
531,089
31
Analysis of changes in net funds - company
1 April 2024
Cash flows
31 December 2024
£
£
£
Cash at bank and in hand
96,629
(71,493)
25,136
SLEEP BRANDS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
- 35 -
32
Prior period adjustment
Reconciliation of changes in equity - group
31 March
2024
£
Adjustments to prior period
Adjusted sales
72,000
Corporation tax provision
(18,000)
Total adjustments
54,000
Equity as previously reported
49,500
Equity as adjusted
103,500
Analysis of the effect upon equity
Profit and loss reserves
54,000
Reconciliation of changes in profit for the previous financial period
March 2024 (unaudited)
£
Adjustments to prior period
Adjusted sales
72,000
Corporation tax provision
(18,000)
Total adjustments
54,000
Profit as previously reported
159,498
Profit as adjusted
213,498
Reconciliation of changes in equity - company
31 March
2024
£
Adjustments to prior period
Adjusted sales
72,000
Corporation tax provision
(18,000)
Total adjustments
54,000
Equity as previously reported
49,500
Equity as adjusted
103,500
Analysis of the effect upon equity
Profit and loss reserves
54,000
SLEEP BRANDS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2024
32
Prior period adjustment
(Continued)
- 36 -
Reconciliation of changes in profit for the previous financial period
March 2024 (unaudited)
£
Adjustments to prior period
Adjusted sales
72,000
Corporation tax provision
(18,000)
Total adjustments
54,000
Profit as previously reported
159,498
Profit as adjusted
213,498
Notes to reconciliation

During the audit of the company accounts for the period to 31 December 2024 an adjustment was noted in relation to the recording of income between accounting periods. A prior year restatement has been made in respects to accruing all income into the relevant period.

2024-12-312024-04-01falsefalseCCH SoftwareCCH Accounts Production 2025.200Mr G A FazioMs K Faziofalse14700315bus:Consolidated2024-04-012024-12-31147003152024-04-012024-12-3114700315bus:Director12024-04-012024-12-3114700315bus:Director22024-04-012024-12-3114700315bus:RegisteredOffice2024-04-012024-12-3114700315bus:Agent12024-04-012024-12-3114700315bus:Agent22024-04-012024-12-31147003152024-12-3114700315bus:Consolidated2024-12-3114700315bus:Consolidated2023-04-012024-03-3114700315bus:Consolidated12024-04-012024-12-3114700315bus:Consolidated12023-04-012024-03-31147003152023-04-012024-03-3114700315core:Goodwillbus:Consolidated2024-12-3114700315core:Goodwillbus:Consolidated2024-03-3114700315core:IntangibleAssetsOtherThanGoodwillbus:Consolidated2024-12-3114700315core:IntangibleAssetsOtherThanGoodwillbus:Consolidated2024-03-3114700315bus:Consolidated2024-03-31147003152024-03-3114700315core:PatentsTrademarksLicencesConcessionsSimilarbus:Consolidated2024-12-3114700315core:DevelopmentCostsCapitalisedDevelopmentExpenditurebus:Consolidated2024-12-3114700315core:PatentsTrademarksLicencesConcessionsSimilarbus:Consolidated2024-03-3114700315core:DevelopmentCostsCapitalisedDevelopmentExpenditurebus:Consolidated2024-03-3114700315core:PatentsTrademarksLicencesConcessionsSimilar2024-12-3114700315core:PatentsTrademarksLicencesConcessionsSimilar2024-03-3114700315core:PlantMachinerybus:Consolidated2024-12-3114700315core:ComputerEquipmentbus:Consolidated2024-12-3114700315core:MotorVehiclesbus:Consolidated2024-12-3114700315core:PlantMachinerybus:Consolidated2024-03-3114700315core:ComputerEquipmentbus:Consolidated2024-03-3114700315core:MotorVehiclesbus:Consolidated2024-03-3114700315core:ComputerEquipment2024-12-3114700315core:MotorVehicles2024-12-3114700315core:ComputerEquipment2024-03-3114700315core:MotorVehicles2024-03-3114700315core:ShareCapitalbus:Consolidated2024-12-3114700315core:ShareCapitalbus:Consolidated2024-03-3114700315core:OtherMiscellaneousReservebus:Consolidated2024-12-3114700315core:OtherMiscellaneousReservebus:Consolidated2024-03-3114700315core:RetainedEarningsAccumulatedLossesbus:Consolidated2024-12-3114700315core:RetainedEarningsAccumulatedLossesbus:Consolidated2024-03-3114700315core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterestsbus:Consolidated2024-12-3114700315core:Non-controllingInterestsbus:Consolidated2024-12-3114700315core:Non-controllingInterestsbus:Consolidated2024-03-3114700315core:ShareCapital2024-12-3114700315core:ShareCapital2024-03-3114700315core:RetainedEarningsAccumulatedLosses2024-12-3114700315core:RetainedEarningsAccumulatedLosses2024-03-3114700315core:ShareCapitalbus:Consolidated2023-03-31147003152023-03-3114700315core:ShareCapital2023-03-3114700315core:RetainedEarningsAccumulatedLosses2023-03-3114700315bus:Director2bus:Consolidated2024-04-012024-12-3114700315core:ShareCapitalbus:Consolidated2023-04-012024-03-3114700315core:ShareCapital2023-04-012024-03-3114700315bus:Consolidated2023-03-3114700315core:Goodwill2024-04-012024-12-3114700315core:IntangibleAssetsOtherThanGoodwill2024-04-012024-12-3114700315core:PatentsTrademarksLicencesConcessionsSimilar2024-04-012024-12-3114700315core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-04-012024-12-3114700315core:PlantMachinery2024-04-012024-12-3114700315core:ComputerEquipment2024-04-012024-12-3114700315core:MotorVehicles2024-04-012024-12-3114700315core:UKTaxbus:Consolidated2024-04-012024-12-3114700315core:UKTaxbus:Consolidated2023-04-012024-03-3114700315core:Goodwillbus:Consolidated2024-03-3114700315core:PatentsTrademarksLicencesConcessionsSimilarbus:Consolidated2024-03-3114700315core:DevelopmentCostsCapitalisedDevelopmentExpenditurebus:Consolidated2024-03-3114700315bus:Consolidated2024-03-3114700315core:PatentsTrademarksLicencesConcessionsSimilar2024-03-3114700315core:Goodwillcore:ExternallyAcquiredIntangibleAssetsbus:Consolidated2024-04-012024-12-3114700315core:PatentsTrademarksLicencesConcessionsSimilarcore:ExternallyAcquiredIntangibleAssetsbus:Consolidated2024-04-012024-12-3114700315core:DevelopmentCostsCapitalisedDevelopmentExpenditurecore:ExternallyAcquiredIntangibleAssetsbus:Consolidated2024-04-012024-12-3114700315core:ExternallyAcquiredIntangibleAssetsbus:Consolidated2024-04-012024-12-3114700315core:Goodwillbus:Consolidated2024-04-012024-12-3114700315core:PatentsTrademarksLicencesConcessionsSimilarbus:Consolidated2024-04-012024-12-3114700315core:DevelopmentCostsCapitalisedDevelopmentExpenditurebus:Consolidated2024-04-012024-12-3114700315core:PlantMachinerybus:Consolidated2024-03-3114700315core:ComputerEquipmentbus:Consolidated2024-03-3114700315core:MotorVehiclesbus:Consolidated2024-03-3114700315core:ComputerEquipment2024-03-3114700315core:MotorVehicles2024-03-31147003152024-03-3114700315core:PlantMachinerybus:Consolidated2024-04-012024-12-3114700315core:ComputerEquipmentbus:Consolidated2024-04-012024-12-3114700315core:MotorVehiclesbus:Consolidated2024-04-012024-12-3114700315core:Subsidiary12024-04-012024-12-3114700315core:Subsidiary22024-04-012024-12-3114700315core:Subsidiary32024-04-012024-12-3114700315core:Subsidiary112024-04-012024-12-3114700315core:Subsidiary222024-04-012024-12-3114700315core:Subsidiary332024-04-012024-12-3114700315core:CurrentFinancialInstruments2024-12-3114700315core:CurrentFinancialInstruments2024-03-3114700315core:Non-currentFinancialInstrumentsbus:Consolidated2024-12-3114700315core:Non-currentFinancialInstrumentsbus:Consolidated2024-03-3114700315core:Non-currentFinancialInstruments2024-12-3114700315core:Non-currentFinancialInstruments2024-03-3114700315core:CurrentFinancialInstrumentsbus:Consolidated2024-12-3114700315core:CurrentFinancialInstrumentsbus:Consolidated2024-03-3114700315core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2024-12-3114700315core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2024-03-3114700315core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3114700315core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3114700315bus:PrivateLimitedCompanyLtd2024-04-012024-12-3114700315bus:FRS1022024-04-012024-12-3114700315bus:Audited2024-04-012024-12-3114700315bus:ConsolidatedGroupCompanyAccounts2024-04-012024-12-3114700315bus:FullAccounts2024-04-012024-12-31xbrli:purexbrli:sharesiso4217:GBP